CADIAN CAPITAL MANAGEMENT, LP - GW PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2018$14,857,000
+14.1%
131,861
+33.6%
0.80%
+1.3%
Q4 2017$13,025,000
+413.4%
98,664
+294.7%
0.79%
+566.4%
Q3 2017$2,537,00025,0000.12%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders